This Article Full Text Full Text (PDF) Other Versions of this Article: JVI.01168-06v1 80/23/11686    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Montag, C. Articles by Hagemeier, C. Search for Related Content PubMed PubMed Citation Articles by Montag, C. Articles by Hagemeier, C.

Human Cytomegalovirus Blocks Tumor Necrosis Factor Alpha- and Interleukin-1ß-Mediated NF-B Signaling

Laboratory of Molecular Biology, Children's Hospital, Charité, Humboldt University Berlin, Berlin, Germany

Received 6 June 2006/ Accepted 12 September 2006

NF-B plays an important role in the early cellular response to pathogens by activating genes involved in inflammation, immune response, and cell proliferation and survival. NF-B is also utilized by many viral pathogens, like human cytomegalovirus (HCMV), to activate their own gene expression programs, reflecting intricate roles for NF-B in both antiviral defense mechanisms and viral physiology. Here we show that the NF-B signaling pathway stimulated by proinflammatory cytokines tumor necrosis factor alpha (TNF-) and interleukin-1ß (IL-1ß) becomes inhibited in HCMV-infected cells. The block to NF-B signaling is first noticeable during the early phase of infection but is fully established only at later times. Biochemical and genetic evidence demonstrates that the viral inhibition of proinflammatory signaling by distinct cytokines occurs upstream of the convergence point of NF-B-activating pathways, i.e., the IB kinase complex, and that it is mediated via different mechanisms. Consistent with this, we further show that an HCMV variant that has lost the ability to downregulate TNF--induced NF-B signaling also fails to downregulate surface expression of TNF receptor 1, thereby mechanistically linking the inhibition of TNF--induced NF-B signaling by HCMV to TNF receptor targeting. Our data support a model whereby HCMV inhibits cytokine-induced NF-B signaling at later times during infection, and we suggest that this contributes to the inhibition of the cell's antiviral defense program.

Published ahead of print on 27 September 2006.

This article has been cited by other articles:

• Le, V. T. K., Trilling, M., Zimmermann, A., Hengel, H. (2008). Mouse cytomegalovirus inhibits beta interferon (IFN-{beta}) gene expression and controls activation pathways of the IFN-{beta} enhanceosome. J. Gen. Virol. 89: 1131-1141 [Abstract] [Full Text]  
• Mack, C., Sickmann, A., Lembo, D., Brune, W. (2008). Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc. Natl. Acad. Sci. USA 105: 3094-3099 [Abstract] [Full Text]  
• El Mjiyad, N., Bontems, S., Gloire, G., Horion, J., Vandevenne, P., Dejardin, E., Piette, J., Sadzot-Delvaux, C. (2007). Varicella-Zoster Virus Modulates NF-{kappa}B Recruitment on Selected Cellular Promoters. J. Virol. 81: 13092-13104 [Abstract] [Full Text]